Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Exelixis Inc (EXEL)

21.64 +0.27 (+1.26%)

3/28/2017  11:42am

Open:

21.43

Pre. Close:

21.37

High:

21.92

Low:

21.37

Volume:

1,054,908

Market Cap:

6.29B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

21.61 - 21.85

21.85 - 22.22

Low:

19.39 - 19.67

19.67 - 20.11

Close:

20.72 - 21.18

21.18 - 21.92

Technical analysis  (as of: 2017-03-28 11:22:25 AM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 25.82     One year: 27.33

Support:

Support1: 20.02    Support2: 16.66

Resistance:

Resistance1: 22.11    Resistance2: 23.40

Pivot:

21.53

Moving Averages:

MA(5): 20.94     MA(20): 21.74

MA(100): 18.46     MA(250): 12.67

MACD:

MACD(12,26): -0.02     Signal(12,26,9): 0.15

%K %D:

%K(14,3): 42.43     %D(3): 28.86

RSI:

RSI(14): 51.85

52-Week:

High: 23.49  Low: 3.64  Change(%): 440.3

Average Vol(K):

3-Month: 5272  10-Days 3887

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
EXEL has closed below upper band by 47.0%. Bollinger Bands are 31.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 14 Mar 2017 11:23:13 GMT
The 3 Most Important Numbers for Exelixis, Inc.

Wed, 01 Mar 2017 15:40:12 GMT
Exelixis, Inc. Turns a Profit, but Don't Get Too Excited

Tue, 28 Mar 2017 12:11:15 GMT
Most Active Stock Update: Exelixis, Inc. (EXEL)

Tue, 07 Mar 2017 13:47:13 GMT
3 Factors That Drove Exelixis, Inc. Higher By 19% in February

Tue, 21 Mar 2017 23:26:15 GMT
Form 4 EXELIXIS, INC. For: Mar 20 Filed by: FELDBAUM CARL B

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

290.87

Shares Float (M)

280.68

% Held by Insiders

17.32

% Held by Institutions

48.10

Shares Short (K)

20430

Shares Short Prior Month (K)

18080

Stock Financials

EPS

-0.280

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.310

PEG Ratio

9.51

Profit Margin

-36.68

Operating Margin

-13.95

Return on Assets (ttm)

-3.6

Return on Equity (ttm)

Qtrly Rev. Growth

680.7

Gross Profit (p.s.)

0.636

Sales Per Share

0.658

EBITDA (p.s.)

-0.088

Qtrly Earnings Growth

Operating Cash Flow (M)

206.30

Levered Free Cash Flow (M)

-16.89

FoxReading.com

Valuation

P/E

-77.18

P/E Growth Ratio

0.01

P/BV

69.71

P/S

32.83

P/CF

30.47

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.